
Tech4Eva, a pioneering accelerator programme dedicated to the femtech sector, is opening its call for applications, inviting femtech start-ups to join its mission to improve women’s health.
The programme is searching for entrepreneurs ready to address the unmet health needs of women worldwide, promising to help entrepreneurs to take their start-ups to the next level.
What is Tech4Eva?
Tech4Eva, is a joint programme between EPFL Innovation Park and Groupe Mutuel for companies developing innovative technology solutions to improve women’s health globally.
What is Tech4Eva looking for?

Why join?
Applying to the Tech4Eva accelerator programme is a pivotal step for any femtech start-up looking to elevate its impact and reach in the women’s health sector.
Here is an overview of the benefits the programme offers:
- Strategic refinement: Sharpen your business model and go-to-market strategy with expert guidance, positioning your start-up for sustainable growth and success.
- Enhanced visibility: Participate in roadshows to showcase your innovative solutions, broadening your exposure to key stakeholders in the Tech4Eva femtech ecosystem.
- Direct connections: Gain invaluable access to a network of investors and potential customers.
- Personalised coaching: Receive targeted technical and business coaching tailored to your start-up’s unique challenges.
- Peer learning: Benefit from Peer2Peer sessions that foster exchange of insights and experiences with fellow founders.
- Community engagement: Become an integral part of a global femtech community, connecting with like-minded innovators committed to transforming women’s health.

The time is now
This is more than a call for applications, it’s a call to action. The Tech4Eva accelerator programme offers more than growth – it offers a chance to be part of a movement set to redefine the future of women’s health.
If your start-up is ready to take the next step, your time is now. Apply here to join the Tech4Eva programme now.

Newsletter
Sign up for free weekly updates
The latest femtech news, research and investment, straight to your inbox.









